| Gurbel, Paul A |
| Recruiting | 3 | 200 | Europe, Canada, US, RoW | Bentracimab (PB2452) Infusion | SFJ Pharmaceuticals, Inc. | Hemorrhage, Urgent Surgery, Invasive Procedure | 08/24 | 08/24 | | |
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) |
|
|
| Recruiting | 3 | 12500 | Europe, Canada, Japan, US, RoW | Lepodisiran Sodium, LY3819469, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 03/29 | 03/29 | | |
NCT06383390: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Renal Function in Adults Living With Obesity (TRIUMPH-OUTCOMES) |
|
|
| Recruiting | 3 | 10000 | Europe, Canada, US, RoW | Retatrutide, LY3437943, Placebo | Eli Lilly and Company | Overweight and Obesity | 02/29 | 02/29 | | |
NCT05625334: Study to Compare the Pharmacodynamics and Pharmacokinetics of Acetylsalicylic Acid Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Healthy Adults. |
|
|
| Completed | 1 | 86 | US | ASA, non-enteric-coated chewable aspirin | Vectura, Inc., Syneos Health | Healthy Volunteers | 03/23 | 03/23 | | |
NCT05625347: Study to Compare the Pharmacokinetics and Pharmacodynamics of ASA Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Adult Subjects With Obstructive or Restrictive Pulmonary Function |
|
|
| Terminated | 1 | 4 | US | single dose (100 mg) of ASA, single dose (162 mg) of non-enteric-coated chewable aspirin tablets | Vectura, Inc., Syneos Health | Obstructive Pulmonary Function, Restrictive Pulmonary Function | 06/23 | 06/23 | | |
| Recruiting | N/A | 100 | US | Phlebotomy | LifeBridge Health, Haemonetics Corporation, Inflammatory Markers Laboratory, Chronolog Corporation, Precision Biologics, Inc | COVID-19 | 02/21 | 06/21 | | |
| Recruiting | N/A | 400 | US | Life and Medication Recommendations | LifeBridge Health, University of Maryland | Acute Coronary Syndrome, Multi Vessel Coronary Artery Disease, Ischemic Stroke | 06/25 | 08/25 | | |
NCT04681040: Risk Stratification of COVID-19 Using Urine Biomarkers |
|
|
| Active, not recruiting | N/A | 964 | Europe, Japan, US, RoW | | National Center for Global Health and Medicine, Japan | Covid19, Urine, Biomarker, Acute Respiratory Failure With Hypoxia | 02/24 | 03/24 | | |
| Active, not recruiting | N/A | 300 | US | Renal Denervation | ReCor Medical, Inc. | Hypertension, Hypertension, Resistant to Conventional Therapy, Vascular Diseases, Cardiovascular Diseases | 12/28 | 12/28 | | |
| Recruiting | N/A | 75 | US | Open Heart Surgery, CABG, Open Heart Valve Replacement | LifeBridge Health, Sinai Center for Thrombosis Research and Drug Development, Accriva Diagnostics | Coronary Artery Bypass Grafting, Open Heart Surgery, Aortic Surgery or Redo Surgery, On-pump Double or Triple Valve Procedures | 12/22 | 01/23 | | |
